Toward a more comprehensive approach to protecting human subjects: the interface of data safety monitoring boards and institutional review boards in randomized clinical trials

IRB. 1998 Jan-Feb;20(1):1-5.
No abstract available

MeSH terms

  • Advisory Committees*
  • Clinical Trials Data Monitoring Committees*
  • Committee Membership
  • Drug Industry
  • Ethical Review
  • Ethics
  • Ethics Committees*
  • Ethics Committees, Research*
  • Federal Government
  • Government
  • Government Regulation
  • Guidelines as Topic
  • Human Experimentation*
  • Multicenter Studies as Topic
  • National Institutes of Health (U.S.)
  • Organization and Administration
  • Random Allocation*
  • Reference Standards*
  • Research Design*
  • Risk
  • Risk Assessment
  • Social Control, Formal
  • United States